Co-Diagnostics Current Ratio 2017-2024 | CODX

Co-Diagnostics current ratio from 2017 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Co-Diagnostics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $0.05B $0.01B 10.19
2023-12-31 $0.06B $0.01B 10.81
2023-09-30 $0.07B $0.01B 13.99
2023-06-30 $0.08B $0.01B 15.13
2023-03-31 $0.09B $0.00B 23.80
2022-12-31 $0.09B $0.00B 23.94
2022-09-30 $0.10B $0.01B 16.95
2022-06-30 $0.12B $0.01B 17.06
2022-03-31 $0.13B $0.01B 9.63
2021-12-31 $0.12B $0.01B 9.14
2021-09-30 $0.10B $0.00B 24.83
2021-06-30 $0.09B $0.01B 19.10
2021-03-31 $0.08B $0.00B 18.38
2020-12-31 $0.07B $0.00B 16.69
2020-09-30 $0.05B $0.00B 28.63
2020-06-30 $0.04B $0.00B 12.36
2020-03-31 $0.02B $0.00B 16.43
2019-12-31 $0.00B $0.00B 4.83
2019-09-30 $0.00B $0.00B 10.02
2019-06-30 $0.01B $0.00B 14.61
2019-03-31 $0.01B $0.00B 16.53
2018-12-31 $0.00B $0.00B 0.45
2018-09-30 $0.00B $0.00B 1.09
2018-06-30 $0.00B $0.00B 6.13
2018-03-31 $0.00B $0.00B 10.98
2017-12-31 $0.00B $0.00B 7.09
2017-09-30 $0.01B $0.00B 8.73
2017-06-30 $0.00B $0.01B 0.07
2017-03-31 $0.00B 0.00
2016-12-31 $0.00B 0.00
2016-09-30 $0.00B 0.00
2016-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.043B $0.007B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $125.903B 15.80
Cencora (COR) United States $47.741B 18.61
ICON (ICLR) Ireland $26.139B 24.68
DiDi Global (DIDIY) China $21.386B 0.00
Avantor (AVTR) United States $15.283B 22.50
CochLear (CHEOY) Australia $14.173B 0.00
Revvity (RVTY) United States $13.191B 23.14
Natera (NTRA) United States $13.190B 0.00
Medpace Holdings (MEDP) United States $12.644B 41.60
Viatris (VTRS) United States $12.466B 3.73
Charles River Laboratories (CRL) United States $10.809B 20.69
EUROFINS SCIENT (ERFSF) Luxembourg $9.137B 0.00
Solventum (SOLV) United States $8.860B 0.00
Sonic Healthcare (SKHHY) Australia $8.681B 0.00
HealthEquity (HQY) United States $7.198B 46.21
Organon (OGN) United States $5.431B 5.15
Bausch + Lomb (BLCO) Canada $5.256B 21.04
Doximity (DOCS) United States $5.107B 35.77
PACS (PACS) United States $4.437B 0.00
Life Times (LTH) United States $3.623B 37.96
Sotera Health (SHC) United States $3.369B 16.53
Surgery Partners (SGRY) United States $3.017B 27.60
GoodRx Holdings (GDRX) United States $2.859B 108.86
Agilon Health (AGL) United States $2.677B 0.00
Progyny (PGNY) United States $2.487B 42.82
AMN Healthcare Services Inc (AMN) United States $2.029B 8.04
NovoCure (NVCR) Jersey $2.014B 0.00
Premier (PINC) United States $1.949B 8.34
BrightSpring Health Services (BTSG) United States $1.852B 0.00
Teladoc Health (TDOC) United States $1.757B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Alignment Healthcare (ALHC) United States $1.449B 0.00
Establishment Labs Holdings (ESTA) $1.226B 0.00
CareDx (CDNA) United States $0.749B 0.00
Embecta (EMBC) United States $0.722B 4.91
GeneDx Holdings (WGS) United States $0.717B 0.00
InnovAge Holding (INNV) United States $0.695B 0.00
Pediatrix Medical (MD) United States $0.680B 7.21
Auna S.A (AUNA) Luxembourg $0.568B 0.00
Sharecare (SHCR) United States $0.497B 0.00
QDM (QDMI) Hong Kong, SAR China $0.437B 11.45
COMPASS Pathways (CMPS) United Kingdom $0.430B 0.00
Enhabit (EHAB) United States $0.426B 42.50
ModivCare (MODV) United States $0.367B 6.87
Sonida Senior Living (SNDA) United States $0.345B 0.00
DocGo (DCGO) United States $0.310B 16.94
LifeMD (LFMD) United States $0.288B 0.00
MultiPlan (MPLN) United States $0.238B 0.00
Beauty Health (SKIN) United States $0.223B 0.00
Sera Prognostics (SERA) United States $0.212B 0.00
Ascend Wellness Holdings (AAWH) United States $0.204B 0.00
Biodesix (BDSX) United States $0.189B 0.00
So-Young (SY) China $0.111B 53.49
Pono Capital Two (PTWO) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.044B 5.88
IceCure Medical (ICCM) Israel $0.035B 0.00
Oncology Institute (TOI) United States $0.031B 0.00
Nutex Health (NUTX) United States $0.029B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.025B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
Singular Genomics Systems (OMIC) United States $0.023B 0.00
OncoCyte (OCX) United States $0.022B 0.00
KindlyMD (KDLY) $0.018B 0.00
BIMI Holdings (BIMI) United States $0.015B 0.00
TRxADE HEALTH (MEDS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
DermTech (DMTK) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00